The pattern of aortic cell responsiveness to Lad is also supportive of the need for combination therapy in AAA, in agreement with the failure in patients of therapies based on IL-8 inhibition, and effective on animal models [36]. This evidence concerns the gene CXCL8 and triple-A syndrome.